TaVNS for Acute Intracerebral Hemorrhage

PHASE2RecruitingINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Intracerebral Hemorrhage
Interventions
DEVICE

transcutaneous auricular vagus nerve stimulation device

Place the stimulation device on the left auricle and set the stimulation parameters according to the following conditions: a. Waveform: biphase, square wave; b. Wave width: 200 μs; c. Frequency: Alternating between low frequency (4 Hz for 4 s), high frequency (40 Hz for 8 s), and a 4 s pause; d. Intensity: The maximum intensity that induces the strongest sensation the individual can tolerate without causing pain, usually 1.5-3.5 mA; e. Treatment duration: Each treatment lasted 30 minutes, twice daily (8:00, 16:00) for 10 days.

DEVICE

Sham device

The sham taVNS group received the same parameters with a current intensity of 0.06 mA.

Trial Locations (1)

100070

RECRUITING

Beijing Tiantan Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06918964 - TaVNS for Acute Intracerebral Hemorrhage | Biotech Hunter | Biotech Hunter